StockData
Sanofi logo

Sanofi (SNYNF) stock

SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30
$78.48−0.07 (-0.09%)

Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –

Sanofi total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Sanofi's total debt was €21.67B at Jun 30, 2026. For fiscal 2025 it was €18.59B, up 16.2% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is €24.69B in fiscal 2019.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025€18.59B+16.2%
FY2024Dec 31, 2024€16.00B-2.4%
FY2023Dec 31, 2023€16.39B-13.9%
FY2022Dec 31, 2022€19.03B-6.3%
FY2021Dec 31, 2021€20.31B-9.8%
FY2020Dec 31, 2020€22.51B-8.8%
FY2019Dec 31, 2019€24.69B+0.2%
FY2018Dec 31, 2018€24.64B+57.9%
FY2017Dec 31, 2017€15.60B-16.0%
FY2016Dec 31, 2016€18.58B+12.2%
FY2015Dec 31, 2015€16.55B–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026€21.67B-0.3%
Q4 FY2025Dec 31, 2025€18.59B+13.4%
Q2 FY2025Jun 30, 2025€20.51B+8.3%
Q4 FY2024Dec 31, 2024€16.00B-15.9%
Q2 FY2024Jun 30, 2024€21.74B+14.4%
Q4 FY2023Dec 31, 2023€16.39B-19.3%
Q2 FY2023Jun 30, 2023€18.94B-6.1%
Q4 FY2022Dec 31, 2022€19.03B-15.5%
Q2 FY2022Jun 30, 2022€19.01B-19.9%
Q4 FY2021Dec 31, 2021€20.31B-17.7%
Q2 FY2021Jun 30, 2021€20.16B-18.2%
Q4 FY2020Dec 31, 2020€22.51B+44.3%
Q2 FY2020Jun 30, 2020€23.73B+27.7%
Q4 FY2019Dec 31, 2019€24.69B+49.1%
Q4 FY2018Dec 31, 2018€24.64B–
Q4 FY2017Dec 31, 2017€15.60B–
Q4 FY2016Dec 31, 2016€18.58B–
Q4 FY2015Dec 31, 2015€16.55B–

More Sanofi figures

See a number that looks wrong?